Skip to content

13F-HR filed by First Turn Management, LLC

First Turn Management, LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 33 holding rows worth $895,098,772.

Accession
0001993440-26-000002
Filed
2026-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 33 entries on the cover page, a total value of $895,098,772 stated on the cover page (in dollars after the unit check, H1), rows summing to $895,098,772 with VALUE read as dollars as filed, 13F file number 028-23631. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
UNITED THERAPEUTICS CORP DEL COM91307C102Stock104,726$62,100,423dollars as filed
ABIVAX SA-00370M103SPONSORED ADS465,869$51,874,513dollars as filed
BRIDGEBIO PHARMA INC10806X102COM695,718$51,664,019dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock786,844$45,754,979dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock468,376$45,549,566dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock513,770$43,244,021dollars as filed
INSMED INC COM PAR $.01457669307Stock248,475$40,630,632dollars as filed
NUVALENT INC COM670703107Stock370,344$37,941,743dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM400,464$36,994,864dollars as filed
COGENT BIOSCIENCES INC19240Q201COM947,339$36,463,078dollars as filed
ROIVANT SCIENCES LTDG76279101SHS1,190,118$32,966,269dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock188,772$31,906,243dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock873,838$29,116,282dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM2,017,284$25,558,988dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock623,839$24,454,489dollars as filed
CELCUITY INC15102K100COM210,578$24,035,373dollars as filed
SCHOLAR ROCK HLDG CORP80706P103COM446,390$21,944,532dollars as filed
KYMERA THERAPEUTICS INC501575104COM254,672$21,211,631dollars as filed
CYTOKINETICS INC23282W605COM NEW283,700$18,698,667dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM220,921$18,539,690dollars as filed
PALVELLA THERAPEUTICS INC697947109COMMON STOCK148,093$18,459,792dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK558,336$17,872,335dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM911,337$17,825,752dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR76,300$17,452,099dollars as filed
FULCRUM THERAPEUTICS INC359616109COMMON STOCK2,256,109$17,304,356dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock326,694$17,223,308dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK422,023$16,977,985dollars as filed
NATERA INC COM632307104Stock81,077$16,214,589dollars as filed
ERASCA INC COM29479A108Stock867,639$14,038,399dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW42,441$13,674,066dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM768,662$11,460,750dollars as filed
UNIQURE NVN90064101SHS615,489$10,063,245dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock315,563$5,882,094dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001993440-26-000002this filing2026-05-15acceptance time not in the bulk data set